109
Views
1
CrossRef citations to date
0
Altmetric
Research

A qualitative exploration of Bahrain and Kuwait herbal medicine registration systems: policy implementation and readiness to change

ORCID Icon, &
Article: 32 | Received 02 Mar 2019, Accepted 09 Aug 2019, Published online: 28 Nov 2023

References

  • World Health Organisation. Legal status of traditional medicines and complimentary/alternative medicine: worldwide review.Switzerland:World Health Organization; 2001. p. 10–14.
  • Wah C, Hock S, Yun T. Current scientific status and regulatory control of traditional/herbal medicinal products: globalization challenges. Pharm Eng. 2012;32(6):1–11.
  • Alostad A, Steinke D, Schafheutle E. International comparison of five herbal medicine registration systems to inform regulation development: United Kingdom, Germany, United States of America, United Arab Emirates and Kingdom of Bahrain. Pharm Med. 2018;32(1):39–49.
  • Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014;4:177.
  • Barnes J. Adverse drug reactions and pharmacovigilance of herbal medicines. Stephens’ detection and evaluation of adverse drug reactions: principles and practice.United Kingdom: Wiley; 2011. p. 645–83.
  • Kanan S, Abu-Yousef I, Gunasekar C, Abdo N, Narasimhan S. Detection and quantification of synthetic drugs in herbal slimming formula. Eur J Sci Res. 2009;34:348–57.
  • Naja F, Alameddine M, Itani L, Shoaib H, Hariri D, Talhouk S. The use of complementary and alternative medicine among Lebanese adults: results from a national survey. Evid Based Complement Alternat Med. 2015;2015:682397.
  • Saad B, Azaizeh H, Said O. Tradition and perspectives of Arab herbal medicine: a review. Evid Based Complement Alternat Med. 2005;2(4):475–9.
  • Sahoo N, Manchikanti P, Dey S. Herbal drugs: standards and regulation. Fitoterapia. 2010;81(6):462–71.
  • Saxena A. How harmless are herbal remedies on human kidneys? Saudi J Kidney Dis Transpl. 2003;14(2):205.
  • Chugh N, Bali S Koul A. Integration of botanicals in contemporary medicine: road blocks, checkpoints and go-ahead signals. Integr Med Res. 2018;7(2):109–210.
  • Kasilo O, Trapsida J, Régional B. Regulation of traditional medicine in the World Health Organisation African region: African health monitor.Regional office for Africa:World Health Organisation; 2010. p. 25–31.
  • World Health Organisation. Developing regional guidelines on minimum requirements for the registration of herbal medicinal products. Report of a workshop.Abu Dhabi: Office for the Eastern Mediterranean: World Health Organisation, Regional; 2004. https://apps.who.int/iris/bitstream/handle/10665/255076/who_em_edb_043_e_en.pdf?sequence=1&isAllowed=y Accessed 8 Nov 2018. 7–9 June 2003
  • Alostad A, Steinke D, Schafheutle E. Herbal medicines pre-marketing registration process in the State of Kuwait: an up-to-date overview of the process. J Pharm Res. 2017;2(2):1–4.
  • Anderson J. Public policymaking.United States: Cengage Learning; 2014.
  • Bowen S, Zwi A. Pathways to “evidence-informed” policy and practice: a framework for action. PLoS Med. 2005;2(7):e166.
  • Oliver K, Innvar S, Lorenc T, Woodman J, Thomas J. A systematic review of barriers to and facilitators of the use of evidence by policymakers. BMC Health Serv Res. 2014;14(1):2.
  • Oliver K, Lorenc T, Innvær S. New directions in evidence-based policy research: a critical analysis of the literature. Health Res Policy Syst. 2014;12(1):34.
  • World Health Organization. WHO traditional medicines strategy 2014–2023.Geneva: World Health Organization; 2013. http://apps.who.int/iris/bitstream/10665/92455/1/9789241506090_eng.pdf?ua=1. Accessed 28 May 2019
  • World Health Organization. Quality control methods for herbal materials. Geneva: World Health Organization; 2011. http://apps.who.int/medicinedocs/documents/h1791e/h1791e.pdf. Accessed 28 May 2019
  • World Health Organization. Guidelines for assessing quality of herbal medicines with reference to contaminants and residues.Geneva: World Health Organization; 2007. http://apps.who.int/medicinedocs/documents/s14878e/s14878e.pdf. Accessed 2 June 2019
  • World Health Organization. The world medicines situation.Geneva: World Health Organization; 2004. http://apps.who.int/medicinedocs/pdf/s6160e/s6160e.pdf. Accessed 28 May 2019
  • WHO traditional medicine strategy 2002–2005. Geneva:World Health Organization;2002. http://www.wpro.who.int/health_technology/book_who_traditional_medicine_strategy_2002_2005.pdf. Accessed 28 May 2019
  • World Health Organization. Report of the inter-regional workshop on intellectual property rights in the context of traditional medicine.Bangkok:World Health Organization; 2000. http://apps.who.int/iris/bitstream/10665/66788/1/WHO_EDM_TRM_2001.1.pdf. Accessed 2 June 2019
  • World Health Organization. Regulatory situation of herbal medicine, worldwide review.Geneva:World Health Organization; 1998. http://apps.who.int/medicinedocs/pdf/whozip57e/whozip57e.pdf. Accessed 28 May 2019
  • Bhat SG. Challenges in the regulation of traditional medicine: a review of global scenario. J Ayurveda Integr Med. 2015;3(6):110–20.
  • Policy Horizons Canada. The case for evidence-based policy. Canada: an organisation within the federal public service. 2016. http://www.horizons.gc.ca/eng/content/case-evidence-based-policy Accessed Jan 28 2019.
  • Smith I. Achieving readiness for organisational change. Libr Manag. 2005;26(7):408–12.
  • Ford J, King D. A framework for examining adaptation readiness. Mitig Adapt Strat Gl. 2015;20(4):505–26.
  • Weiner B. A theory of organizational readiness for change. Implement Sci. 2009;4(1):67.
  • Weiner B, Amick H, Lee S. Conceptualization and measurement of organizational readiness for change: a review of the literature in health services research and other fields. Med Care Res Rev. 2008;65(4):379–436.
  • Godin G, Bélanger-Gravel A, Eccles M, Grimshaw J. Healthcare professionals’ intentions and behaviours: a systematic review of studies based on social cognitive theories. Implement Sci. 2008;3(1):36.
  • ICEBeRG. Designing theoretically-informed implementation interventions. Implement Sci. 2006;1(1):4.
  • Mitchell S, Fisher C, Hastings C, Silverman L, Wallen G. A thematic analysis of theoretical models for translational science in nursing: mapping the field. Nurs Outlook. 2010;58(6):287–300.
  • Walt G, Gilson L. Reforming the health sector in developing countries: the central role of policy analysis. Health Policy Plan. 1994;9(4):353–70.
  • Al Adel D, Pahuja R. Update on the Classification of Pharmaceutical Products in Bahrain. Bahrain: ATamimi & Co; 2016. https://www.tamimi.com/law-update-articles/update-on-the-classification-of-pharmaceutical-products-in-bahrain/ Accessed Dec 12 2018
  • Buse K, Dickinson C, Gilson L, Murray S. How can the analysis of process and power improve health outcomes? Moving the agenda forward [briefing paper 25].London:Overseas Development Institute; 2007.
  • Walt G, Shiffman J, Schneider H, Murray S, Brugha R, Gilson L. ‘Doing’ health policy analysis: methodological and conceptual reflections and challenges. Health Policy Plan. 2008;23(5):308–317.
  • Damschroder L, Aron D, Keith R, Kirsh S, Alexander J, Lowery J. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4(1):50.
  • Feldstein A, Glasgow R. A practical, robust implementation and sustainability model (PRISM) for integrating research findings into practice. Jt Comm J Qual Patient Saf. 2008;34(4):228–243.
  • Gagnon M, Labonté R. Understanding how and why health is integrated into foreign policy-a case study of health is global, a UK government strategy 2008–2013. Glob Health. 2013;9(1):24.
  • Glanz K, Bishop D. The role of behavioural science theory in development and implementation of public health interventions. Annu Rev Public Health. 2010;31:399–418.
  • Nilsen P. Making sense of implementation theories, models and frameworks. Implement Sci. 2015;10(1):53.
  • Srivastava A, Thomson S. Framework analysis: a qualitative methodology for applied policy research. JOAAG. 2009;4:72–79.
  • LeDoux L, Guilbeau R, Kirk S, Baker N. Strategic planning: managing strategically. United States: Texas Workforce Commission, training and development department; 2005.
  • Amatayakul M. EHR? Assess readiness first: there’s no denying interest in electronic health records is increasing. Healthc Financ Manage. 2005;59(5):112–114.
  • Bhuyan A, Jorgensen A, Sharma S. Taking the pulse of policy: the policy implementation assessment tool. Washington DC: USAID; 2010. http://www.healthpolicyplus.com/archive/ns/pubs/hpi/1086_1_PIAT_Summary_Taking_the_Pulse_of_Policy_acc.pdf Accessed Dec 12 2018
  • Alharbi M. An analysis of the Saudi health-care system’s readiness to change in the context of the Saudi National Health-care Plan in vision 2030. Int J Health Sci. 2018;12(3):83.
  • Gill R. Change management--or change leadership? J Chang Manag. 2008;3(4):307–318.
  • Sofarelli D, Brown D. The need for nursing leadership in uncertain times. J Nurs Manag. 1998;6(4):201–207.
  • Hajer M, Hajer MA, Wagenaar H. Deliberative policy analysis: understanding governance in the network society. Cambridge: Cambridge University Press; 2003.
  • Dobrow M, Goel V, Upshur R. Evidence-based health policy: context and utilisation. Soc Sci Med. 2004;58(1):207–217.
  • El-Jardali F, Makhoul J, Jamal D, Ranson M, Kronfol N, Tchaghchagian V. Eliciting policymakers’ and stakeholders’ opinions to help shape health system research priorities in the Middle East and North Africa region. Health Policy Plan. 2009;25(1):15–27.
  • Lazzerini M, Ciuch M, Rusconi S, Covi B. Facilitators and barriers to the effective implementation of the individual maternal near-miss case reviews in low/middle-income countries: a systematic review of qualitative studies. Br Med J. 2018;8(6):e021281.
  • Al-Essa R, Al-Rubaie M, Walker S, Salek S. Pharmaceutical regulatory environment: challenges and opportunities in the Gulf region. Switzerland:Springer; 2011.